![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 31, 27697-27705, August 2, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129
Received for publication, February 19, 2002, and in revised form, May 3, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Ikaros is a key regulator of the hemo-lymphoid
system in which it is presumed to function by both potentiating and
repressing gene expression. Repression is mediated through two
independent domains at the N and C terminus of the protein, both of
which can independently recruit the corepressors Mi-2 Ikaros (1) is the founding member of a Kruppel zinc finger family
that includes Aiolos (2), Helios (3, 4) and Eos (5). The most
full-length form of all these proteins is characterized by an
N-terminal zinc finger DNA binding domain (6, 7) and two C-terminal
zinc fingers related to the Drosophila gap protein
hunchback, which are involved in interactions with self and with
members of the family (8). Ikaros is comprised of seven
exons from which at least eight isoforms (Ik1-8) can be generated
through alternate splicing of exons 3-6 (6, 7). Exons 3-5 contain the
DNA-binding zinc fingers, and their varying utilization results in
Ikaros isoforms that can be distinguished by their ability to bind DNA
(6, 7). The non-DNA-binding Ikaros isoforms, such as Ik6 and Ik7,
interfere with the function of the DNA-binding forms and thereby can
function as naturally occurring dominant-negative proteins (8).
Mutations in the murine Ikaros and Aiolos loci,
which prevent their expression and/or which exclusively generate
dominant-negative proteins, have firmly established the importance of
these genes in hemo-lymphoid development, differentiation, and
homeostasis (9-12).
Ikaros and all its isoforms are capable of potent repression when
tethered upstream of a promoter through a heterologous DNA-binding domain. Repression is effected through two domains found at the N and C
terminus of the protein and, in some promoter contexts, depends upon
the activity of histone deacetylases
(HDACs)1 (13). It is widely
presumed that HDACs contribute to repression by deacetylating lysines
found at the N-terminal tails of histones H3 and H4 thereby
facilitating a compact, closed chromatin configuration that is
non-permissive for transcription (14).
HDAC proteins can be divided into at least three different classes
based on sequence homology, expression, localization, and cofactor
requirements: HDACs 1, 2, 3, and 8 comprise Class I, HDACs 4-7 belong
to Class II, and SIRT 1-7 are members of Class III (15). Class I HDACs
are nuclear and largely ubiquitous, whereas Class II HDACs are
cytoplasmic (until they receive appropriate signals, whereupon they are
imported to the nucleus) and more tissue-restricted (15). Class III
proteins are NAD+-dependent histone deacetylases, which may
also be involved in other histone modulating functions like
ubiquitination (15).
In mammalian cells, Class I HDACs are primarily recruited to target
genes through corepressor complexes containing either Sin3A, Sin3B (14,
16), Co-REST (17-19), or the chromatin remodeler Mi-2 We have previously shown that both the N- and C-terminal repression
domains of Ikaros can interact with the corepressors, Sin3A, Sin3B,
Sin3BSF (a shorter isoform of Sin3B), Mi-2 Plasmids--
Deletion mutations of the N- and C-terminal
repression domains (IKD2 and IKD4) of Ik1 and deletion mutants of Ik6
were generated by cloning the relevant regions into the BXG1 vector,
which encodes the Gal4 DNA binding domain (DBD) (amino acids 1-147)
under the control of the SV40 promoter or into a CDM8Flag vector.
CDM8-Ik1, -Flag-Aio3, -Flag-Helios, -Flag-Eos (Daedalus), -Mi2 Transfections--
293T and NIH3T3 cell lines were maintained in
Dulbecco's modified Eagle's medium with 10% fetal bovine serum
(Hyclone). Transfections of these cell lines were carried out using the
HBS-CaP04 method. For repression assays, 1 µg of the Gal4 fusion
plasmid, 10 µg of the Gal4 reporter plasmid, and 0.5 µg of the
pXGH5 growth hormone transfection efficiency control plasmid were used.
Twenty-four hours after transfection, cells were fed with fresh media,
and 18-24 h later cells were harvested and processed for CAT assays as
described (8). Growth hormone assays were done as recommended by the
manufacturer (Nichols Institute). Transfections were typically performed in duplicate and repeated between three and six times.
Immunoprecipitation and Western Analysis--
Whole cell
extracts from 293T cells transfected with the relevant plasmids were
prepared as previously described (8) and precleared using
protein-G-agarose beads (Roche Molecular Biochemicals). The precleared
extracts were incubated with the antibody of interest or the relevant
isotype control on ice for 1 h. 30 µl of protein-G beads were
then added to the extract, and the extracts were rotated overnight. The
beads were collected by centrifugation and washed four times with
TS buffer (150 mM NaCl, 20 mM Tris, pH
7.5). The beads obtained after this procedure were treated with SDS
sample buffer, boiled at 95 °C for 15 min, and loaded on an
SDS-polyacrylamide gel along with 8-10% of the cell extract used for
the immunoprecipitation. The proteins were transferred to a
nitrocellulose membrane, probed with the relevant antibody, and
examined by autoradiography with ECL (Amersham Biosciences).
Antibodies used were: Myc tag (MT) (Roche Molecular Biochemicals), HA
(BabCO), FLAG M2 (Sigma), Gal4, Sin3B (Santa Cruz), HDAC2
(Zymed Laboratories Inc.), and anti-Ikaros and Mi-2,
which have been previously described (22).
Dissection of the Two Repression Domains of Ikaros--
We have
previously shown the existence of two repression domains in Ikaros
namely, IKD2 and IKD4 (see Fig.
1A, constructs 2 and 14 respectively) (13). To delineate the minimal regions capable of repression within these two domains, we constructed a series
of N- and C-terminal deletions in the context of the Gal4 DBD. Each of
these constructs was first tested for expression (Fig. 1B)
and then transfected together with a thymidine kinase promoter-CAT
reporter engineered with five Gal4 binding sites (G5tkCAT) into NIH3T3
cells to assay the ability of the encoded proteins to repress
transcription.
The N-terminal repression domain, IKD2, and all of its deletion
derivatives were capable of repression, albeit to differing levels
(Fig. 1A, constructs 2-11). Repression was
maximal when all four N-terminal zinc fingers were present; however,
deleting all four N-terminal zinc fingers still permitted the resulting region to repress transcription (Fig. 1A, construct
8). In contrast, not all derivatives of the C-terminal repression
domain function as repressors (Fig. 1A, constructs
12-20); the region containing the two C-terminal zinc fingers was
essential for repression. Mutation of these zinc fingers, either by
point mutations that alter their ability to dimerize or by deletion of
one or both fingers, reduces or abolishes the repressive function of
this region (Fig. 1A, compare construct 12 to
13; 14 to 15 and 16; and
17 to 18 and 19). However, a region
comprising the C-terminal zinc fingers was, by itself, only capable of
modest repression (Fig. 1A, construct 20). This
region may need to operate in the context of a larger domain and thus
not function effectively when directly tethered to the Gal4 DBD.
In summary, the N-and C-terminal repression domains of Ikaros can be
distinguished by the behavior of their deletion derivatives; the former
is comprised of several smaller apparently redundant repression
modules, whereas the latter is critically dependent on one region that
contains the C-terminal zinc fingers.
Corepressor Interactions Required for Repression by Ikaros
Domains--
In previous reports we have shown that Ikaros is a
component of the Mi-2
The N-terminal Ikaros repression domain, IKD2, can interact with the
corepressors, Sin3A (Fig. 2A),
Sin3BSF (B), Mi-2
The C-terminal repression domain, IKD4, also interacted with Sin3 (Fig.
2, A and B) and Mi-2
Taken together these data indicate that Ikaros contains several
distinct interaction interfaces for corepressor molecules (shown over
the Ikaros schematic in Fig. 1A). The N-terminal half of the
Ikaros protein contains sites that promote binding of Sin3, Mi-2 Reversal of Ik6 Repression Relies on the Abrogation of Mi-2
A series of Ik6 deletion mutants were generated (Fig.
3C) and tested for their
ability to interact with the corepressors of Ikaros. Deletion of 33 amino acids within the 97-amino acid region identified as the
C-terminal Sin3 interaction module (Fig. 1A, IKD8),
abolished interactions of Ik6 with Sin3A, Sin3B, and Sin3BSF without
affecting interactions with Mi-2
Given that Ik6 lacks a DNA binding domain, its corepressor interaction
mutants were tested for their ability to repress transcription in the
context of the Gal4 DBD. The CtBP interaction mutant (M1) was impaired
by over 50% compared with wild type in its ability to repress
transcription, while the Sin3 interaction mutant (M6) was only modestly
affected (Fig. 4). A mutation that
abolished Mi-2
Mutations that prevent Ikaros interactions with self and family, M12,
M14, and M15, also decreased repression. As these mutations do not
appear to affect interactions with Mi-2 Corepressor Interactions with Ikaros Family Members--
Ikaros is
the prototype of a family of transcription factors that exhibit a
restricted pattern of expression in hemopoietic, neuronal, and
epithelial tissues (2-5). The non-hemopoietic Ikaros family members
may play a similar role to Ikaros in the developmental systems where
they are present. We therefore examined whether the Ikaros corepressor
interactions were conserved between its family members. Aiolos, Helios,
and Eos were expressed either alone or in combination with a subset of
corepressors. Using immunoprecipitation assays, we found that all
Ikaros family members could interact with ectopically expressed Sin3A
(Fig. 5A) and Sin3B
(B) and endogenous Mi-2
Since our initial description of Ikaros interactions with Class I
HDACs, other classes of HDACs have been identified that also function
in repression. Ikaros and all its family members were tested for
interactions with Class II HDACs. All Ikaros family members interacted
best with HDAC5 (Fig. 5E) and to a lesser but differing
extent with HDACs 4 and 7; Helios interactions with these HDACs are
almost undetectable, whereas Eos interacts with them most strongly
among the Ikaros family (Fig. 5E). We also compared binding
of Ikaros with the two classes of HDACs. Ik1 was co-transfected with
the Class I HDACs 1 and 3 or the Class II HDACs 4, 5, and 7. Immunoprecipitation assays revealed that Ikaros interacted more
strongly with Class I HDACs compared with any of the Class II members
(Fig. 5F).
In summary, Ikaros family members can interact with all of the
identified corepressors of Ikaros except CtBP. Thus, they too may play
a role in gene repression. In agreement with this expectation, both
Aiolos (13) and Eos (27), like Ikaros, have been shown to be capable of repression.
We have previously shown that Ikaros can function as a potent
repressor when recruited to promoters through a heterologous DNA
binding domain (13). This function, at least in certain contexts, is
mediated through the action of histone deacetylases (13). Consistent
with this observation, Ikaros has been shown to be associated with at
least two distinct HDAC complexes containing the corepressors Mi-2 A systematic dissection of the two Ikaros repression domains has
allowed the identification of interaction interfaces on Ikaros for its
corepressors (see Fig. 1A). We have previously shown that CtBP1 binds Ikaros through a PEDLS motif within the N-terminal repression domain (23). Unlike CtBP, the Sin3, Mi-2 In agreement with the corepressor interaction modules described above,
the N-terminal repression domain, IKD2, can be broken into smaller
subregions, all of which can repress transcription, whereas the
C-terminal domain, IKD4, can only function effectively when the region
spanning the two C-terminal zinc fingers are intact. Interestingly, the
tricho-rhino-phalangeal syndrome protein 1 (TRPS1), which contains two
zinc fingers with extensive homology to those at the C terminus of
Ikaros (24), also cannot repress transcription when this domain is
deleted (25). Thus, the C-terminal zinc finger domain, which is found
in proteins as early as Drosophila hunchback (26) and in
proteins otherwise unrelated to Ikaros such as Pegasus (27) and TRPS1
(24), appears to be an evolutionarily conserved module involved in
dimerization as well as gene repression.
Repression mediated by each subregion of the two repression domains of
Ikaros correlated with their interactions with at least one of the
corepressors of Ikaros. In the context of the N-terminal repression
domain, subregions that could not interact with CtBP, Sin3, or Mi-2 Another interesting observation from these studies was that several
subregions that interacted with the corepressor Sin3 were incapable of
supporting repression (IKD11, IKD4B, IKD8). This suggests that
corepressor interaction per se is insufficient, in some
cases, for repression; in these instances the corepressors may need to
be assembled into a higher order complex (for which other regions are
presumably required) to effectively turn off gene expression.
Alternatively, Sin3 may play a role different from transcriptional
repression in the context of Ikaros.
Based on these collective findings, we targeted mutations in the
smallest and most potent Ikaros isoform, Ik6, to construct a
repression-defective Ikaros protein. A mutation in Ik6 that prevented
the corepressor Sin3 from binding Ikaros had only minimal effects on
repression. In contrast, a mutation that abrogated CtBP binding reduced
repression by 50%. A deletion of the C-terminal zinc fingers, which
abolished Mi-2 In contrast to the results obtained for Ik6, mutations of the
C-terminal zinc fingers in the context of the most full-length Ikaros
isoform, Ik1, had no significant impact on repression (13). This may be
explained by the presence, in the full-length protein, of the
additional N-terminal repression domain, which can interact with all
corepressors found at the C terminus domain as well as CtBP, which may
rescue the defect caused by the alteration of the dimerization module
(13).
We extended our study of corepressor interactions to the family members
of Ikaros. Like Ikaros, its three family members can bind all the
Ikaros-interacting corepressors that we have tested (Sin3A, Sin3B,
Mi-2, and Class I HDACs), with the exception of CtBP. CtBP, was
recently shown to be capable of binding the Class II HDACs (28), and we
have found that the Class II deacetylases, HDACs 5 and 6, can bind
Ikaros. Class II HDACs can also bind Ikaros family members, but because
they do not interact with CtBP (23), it is likely that the HDACs are
recruited to them through CtBP-independent mechanisms. Given both the
strong homologies between Ikaros family members and the conservation of
most corepressor interactions, we expect that the findings with Ikaros
may be extended to its family. Indeed, both Aiolos and Eos have been
shown to be capable of repressing transcription (13, 27).
Several reports have indicated that aberrant repression may play an
important role in carcinogenesis (29). In this context, it is
noteworthy that mice expressing dominant-negative Ikaros proteins
(e.g. Ik6) develop leukemias and lymphomas with complete penetrance (10). It has been argued that these cancers may arise because of the cellular anomalies that result from the titration of
DNA-binding Ikaros family proteins from their binding sites by the
dominant-negative proteins (1). In addition, it is also possible that
the large-scale incorporation of Ik6 into Ikaros complexes may alter
their transcriptional function to a predominantly repressive role,
which could severely impact lymphocyte homeostasis. The identification
of a repression-defective dominant-negative Ikaros protein may permit a
distinction between the role of aberrant repression versus
that of titration of Ikaros family members in dominant-negative
Ikaros-mediated lymphomagenesis.
In conclusion, in this report we have (a) identified the
minimal repression modules and corepressor interaction interfaces on
Ikaros, (b) uncovered redundancies in corepressor
interaction modules involved in Ikaros-mediated repression,
(c) constructed Ikaros proteins defective for interaction
with the majority of the corepressors of Ikaros, and (d)
shown the importance of Mi-2
, Sin3A, and
Sin3B and the Class I histone deacetylases 1 and 2; the
N-terminal domain can also associate with the corepressor CtBP. Here we
describe a detailed dissection of these two domains and identify the
minimal repression modules and the corepressor requirements for their activity. Based on these studies, we describe mutations in a
full-length Ikaros protein that abrogate interactions with each of the
identified corepressors and abolish the protein's function as a
repressor. Finally, we show that, barring CtBP, the Ikaros family
members Aiolos, Helios, and Eos can associate with all of the
identified corepressors of Ikaros including its newly identified
interactors, Class II HDACs.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(14, 16).
Both the Sin3 and Mi-2
proteins interact with a core complex
containing the Class I HDACs 1 and 2 and the Rb-associated proteins
(RbAp), RbAp46 and RbAp48, but differ in the other proteins that they
each associate with (14). Also, both the Sin3- and Mi-2
-containing
complexes contain deacetylase and chromatin-remodeling activities (14,
20). The Sin3-HDAC complex is presumed to be recruited to
euchromatic regions to transiently shut down genes, while the
Mi-2
-containing nucleosome remodeling and deacetylation complex is
thought to be involved in actively maintaining repression in
heterochromatic regions. The CoREST complex, which has only recently
been described, does not contain any components in common with either
the Sin3 or the Mi-2
complexes other than the Class I HDACs
(17-19). In contrast to the Class I deacetylase complexes, Class II
HDACs are found in association with the nuclear receptor corepressors,
N-CoR or SMRT, and the Class I HDAC3 (21).
, and Class I HDACs 1 & 2 (13, 22), while the N-terminal repression module can also interact with
the corepressor CtBP through a PEDLS motif found in exon 2 (23). Here,
we provide a detailed characterization of these two repression domains
and identify the minimal regions within them that are required for
repression and the corepressors that contribute to their function. We
also describe mutations that prevent interactions with each of these
corepressors and which can convert the strongest transcriptional
repressor of the Ikaros isoforms, Ik6, into a transcriptionally neutral
protein. Finally, we show that, with the exception of CtBP, all Ikaros family members are capable of interactions with the identified corepressors of Ikaros, which suggests that they too may play a role in
gene repression.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
,
-MT-Sin3A, -HA-Sin3B, pCMV2-FlagIk1, -FlagIk1 cm, BXG1-Ik6, and the
reporter G5tkCAT have been previously reported (13, 23). Flag-HDAC3 was
provided by Dr. E. Seto, MT-HDAC4 was provided by Dr. M. Lazar, and
HA-HDAC5 and -HDAC7 were provided by Dr. R. Evans.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (41K):
[in a new window]
Fig. 1.
Dissection of the two repression domains of
Ikaros. A, schematic representation of Ik1 and its
subregions. Exons (E) are indicated as horizontal
rectangles, and zinc fingers by vertical
rectangles. The absence of vertical rectangles for construct 18 indicates that its zinc fingers have been mutated to prevent
dimerization. The repression supported by each subregion is tabulated
adjacent to its diagrammatic representation. The amino acids
delineating each subregion are indicated. NIH3T3 cells were transfected
with the indicated Gal4 constructs (BXG1, 1 µg), the reporter G5tkCAT
(10 µg), and pXGH5 (1 µg), a growth hormone-expressing vector to
account for differences in transfection efficiency. Fold repression was
calculated by dividing the CAT activity supported by each BXG1-Ikaros
subregion (measured as cpm) by the CAT activity of the BXG1 vector
alone. The fold repression values are the average of transfections done
in duplicate six different times. The variation between independent
experiments was less than 20%. Also indicated in the table are the
results of interaction mapping studies of each of these subregions with
the corepressors of Ikaros: Sin3A, Sin3BSF, Mi-2
, HDAC2, and CtBP,
which were performed as described in Fig. 2. Binding is indicated as +,
and its lack thereof as
. n.d. stands for not done. Please note that
binding should not be taken to mean strength of interaction. The
asterisk (*) identifies those interaction assays that were
performed in yeast. The binding data for CtBP1 is based on previously
published data (23). The minimal interaction interfaces for the tested
corepressors, gleaned from these studies, is indicated above the
schematic of Ik1, whereas the functional domains are indicated below.
B, 293T cells were transfected with each of the Gal4-tagged
Ikaros subregions diagrammed in A. Whole cell lysates were
prepared and analyzed by immunoblot analysis using Gal4 antibodies to
detect expression. The numbers listed above the blot correspond to the
number assigned to each subregion in A. The
arrowhead identifies a cross-reacting band.
/nucleosome remodeling and deacetylation
complex and Sin3-HDAC chromatin-modifying complexes in
lymphocytes (13, 22); in addition, it also interacts with the
corepressor CtBP (23). We set out to examine whether these interactions
were responsible for the activity of the Ikaros N- and C-terminal
repression regions.
(C), HDAC2 (D),
and CtBP (23). C-terminal deletions of this domain altered its
interactions with the Mi-2
and Sin3 proteins; in particular, removal
of the third and fourth zinc fingers severely compromised interactions
with Mi-2
(Figs. 1A and 2C, compare IKD2B to
IKD2C) and Sin3 proteins (Figs. 1A and 2, A and
B, compare IKD2 to IKD2C and IKD2D). N-terminal deletions of
IKD2 that left all four zinc fingers intact had no effect on Mi-2
(Figs. 1A and 2C, IKD13 and -14) but did have a
small effect on Sin3 interactions (Fig. 2A, IKD14).
Interestingly, the deletion mutants, which were unable to interact with
Sin3 and Mi-2
, were still capable of repression (see Fig.
1A, IKD2C; Fig. 2D, N1, N2, and IKD15). This may
be due to their ability to still interact with HDAC2 (Figs. 1A and 2D) and CtBP1 (Fig. 1A). CtBP1
was previously shown to interact with Ikaros through a PEDLS motif
(23), which is located upstream of the Sin3 and Mi-2
interaction
domains. Nonetheless, deletion of the CtBP interaction motif in the
context of a region that contained the Sin3 and Mi2
interaction
interfaces had minimal effects on the repressive activity of the
resulting region (Fig. 1A, IKD13, IKD14). Finally, a
deletion designed to abrogate CtBP, Sin3, and Mi-2
interactions at
the N-terminal region of Ikaros was still capable of repression (Fig.
1A, IKD15); however, this deletion mutant was still capable
of interactions with HDAC2 (Fig. 1A, construct
11; Fig. 2D).

View larger version (72K):
[in a new window]
Fig. 2.
Identification of interaction domains of the
corepressors of Ikaros. A, a representative immunoblot
of the Sin3A interaction assay data reported in Fig. 1A.
293T cells were transfected with the indicated BXG1-Ikaros subregions
and MT-Sin3A. Whole cell lysates were incubated with antibodies to the
Myc epitope. A Western blot of the immunoprecipitated (IP)
proteins were immunoblotted (IB) with Gal4 antibodies to
detect interaction between the subregions and Sin3A. Blots were
stripped and reprobed with Myc antibody to confirm that Sin3A was
indeed expressed and immunoprecipitated. I, input;
C, isotype control IP; B, bound fraction from
specific IP. B, a representative immunoblot of the Sin3BSF
interaction assay data reported in Fig. 1A. Interaction
assay was performed as in A with the indicated antibodies.
C, a sample of the Mi-2 interaction assay data reported in
Fig. 1A. D, a representative immunoblot of the
HDAC2 interaction assay data reported in Fig. 1A. The
arrowhead adjacent to the immunoblot identifies the band
corresponding to HDAC2. The region marked by an asterisk (*)
indicates the heavy chain of the immunoprecipitating antibody.
and HDAC2 (Fig.
2D) but not with CtBP. A 97-amino acid module spanning
residues 361-457, located upstream of the self-interaction zinc
fingers (Fig. 2B, IKD8), could support Sin3 interactions;
interestingly, this region was incapable of repression (Fig.
1A, constructs 13, 16 and
19). The smallest region capable of interaction with the
chromatin remodeler, Mi-2
, at the C terminus was mapped previously
by yeast two-hybrid assays and spans amino acids 457-518, which
contain the two self-interaction fingers of Ikaros; deletion mutants of
this region are unable to repress. This is in contrast to the
N-terminal subregions that are unable to interact with Mi-2
but
which are still capable of repression (Fig. 1A, compare
construct 4 to 5 and 7). HDAC2 interactions at the C terminus resemble those of Mi-2
but not Sin3:
HDAC2 interacts with IKD5, which interacts with Mi-2
but not with
IKD8, which interacts with Sin3 (Fig. 1A). Thus, HDAC2 may
be recruited to the C terminus of Ikaros through Mi-2
and not Sin3.
,
HDAC2, and CtBP. Mutations that ablate any one of these corepressor
interaction interfaces compromise, but do not ablate, the repression
potential of this region. Thus there is an apparent redundancy for
repressor function in this part of the molecule. In contrast, although
the C-terminal half of the Ikaros protein can also bind Sin3, Mi-2
,
and HDAC2, repression activity appears to rely predominantly on the
C-terminal interaction zinc fingers, which are part of the Mi-2
and
HDAC2 but not the Sin3 interaction interface.
,
HDAC2, and CtBP Interactions--
Having identified regions of the
Ikaros protein with the potential to repress and interact with its
known corepressors, we set out to determine the role of a subset of
these putative interaction interfaces in the context of the smallest
full-length Ikaros protein, the Ik6 isoform. Ik6 represents a subclass
of Ikaros isoforms that lack a DNA binding domain and which have been
implicated in leukemogenesis (10). Therefore, delineating the
transcriptional functions of this Ikaros isoform could be important in
dissecting its role in leukemogenesis. Interestingly, Ik6 is the
strongest repressor of all Ikaros isoforms when recruited to DNA
through a heterologous DNA binding domain (13).
or HDAC2 (Fig. 3, A and
C, M6, and data not shown). A different deletion in the
region encompassing the two C-terminal zinc fingers of Ikaros abolished interactions with Mi-2
and dramatically reduced interactions with
HDAC2 (Fig. 3 B and C, M17). We have previously
shown that a mutation of the PEDLS motif at the N terminus of Ikaros
ablates its interactions with the corepressor CtBP (23).

View larger version (49K):
[in a new window]
Fig. 3.
Generation of mutations in Ik6 that abrogate
corepressor interactions. A, 293T cells were
transfected with wild type Ik6 and Ik6 mutants (diagrammatically
represented in C) alone or in combination with MT-Sin3A or
HA-Sin3B (long form). Whole cell lysates prepared from the transfected
cells were immunoprecipitated (IP) with antibodies raised to
Ikaros or isotype control antibody (mouse IgG, mIgG) and
immunoblotted (IB) with the indicated antibodies to test for
binding the ectopically expressed Sin3 or the endogenous Mi-2
and
HDAC2 proteins. Blots were stripped and reprobed with Ikaros antibodies
to confirm that each of the proteins were made and precipitated.
B, wild type Ik6 and deletion mutants (see C)
were transfected into 293T cells. Whole cell lysates were
immunoprecipitated as described in A. Immunoblots were
probed sequentially with antibodies to detect interactions between
Ikaros and endogenous Mi-2 and HDAC2. C, a diagrammatic
representation of the Ik6 proteins used for mapping corepressor
interaction mutants alongside the results from this study. The
horizontal rectangles indicate exons (E), whereas
the vertical rectangles indicate the two C-terminal zinc
fingers. The lack of a vertical rectangle indicates point mutations in
the corresponding finger that convert the two cysteines of the
corresponding finger to glycines, which abrogate interactions with
Ikaros or its family. The asterisk identifies a DL
AS
mutation in exon2 of Ikaros that prevents its association with the
corepressor CtBP. + signifies interaction, ± signifies a significant
reduction in interaction compared with the wild type,
indicates lack
of interaction, and n.d. indicates that the interaction has not been
tested. D, a schematic representation of the data in
C.
binding and significantly altered HDAC2 association
(M17) could repress to only 20% of wild type levels (Fig. 4). When
this mutation was combined with one that prevented CtBP interaction (M18), repression was completely abolished (Fig. 4). Thus, Mi-2
, HDAC2, and CtBP appear to play key roles in Ik6-mediated
repression.

View larger version (21K):
[in a new window]
Fig. 4.
Transcriptional repression by Ik6 and is
corepressor interaction mutants. NIH3T3 cells were transfected
with 1 µg of the indicated Gal4 constructs (BXG1), the reporter
G5tkCAT (10 µg), and the transfection efficiency control plasmid,
pXGH5 (0.5 µg). Fold repression was calculated as described in Fig.
1A. The data represents the average of duplicate
transfections repeated four times. Variation between experiments was
less than 20%. A schematic diagram of Ik6 and its variants is
presented; the filled square in the figure serves to depict
the DNA binding domain of Gal4. Vertical rectangles indicates the
presence of the two C-terminal zinc fingers. The absence of this
notation indicates a mutation of the two cysteines to glycines in the
corresponding C-terminal zinc finger, which has the effect of
preventing self and heteromeric interactions. The asterisk
(*) identifies a mutation of DL to AS in the CtBP interaction motif of
Ik6 that prevents its interaction with this corepressor (23). Wherever
a deletion has been made the amino acids deleted are indicated
(dl).
, HDAC2, and presumably CtBP
(Fig. 3, B and C), decreased repression may
result from an altered Ik6/corepressor configuration that prevents
efficient repression, or alternatively, these mutants may be defective
in interactions with other yet-to-be identified Ikaros corepressors.
(C) and Class I HDAC2
(D).

View larger version (62K):
[in a new window]
Fig. 5.
Conservation of corepressor interactions
across Ikaros family members. A, 293T cells were
co-transfected with 10 µg each of an expression vector for MT-Sin3A
and the FLAG-tagged Ikaros family members, Aiolos (FLAG-A), Helios
(FLAG-H), or Eos (FLAG-E). IP were performed on whole cell lysates with
antibodies to the FLAG epitope. IB analysis with antibodies to the Myc
epitope (MT) revealed interactions between the Ikaros family
members and Sin3A. Blots were stripped and reprobed with the antibody
used for the IP to ascertain that the epitope-tagged proteins were
indeed immunoprecipitated. I, input; C, isotype
control IP; B, bound fraction from specific IP. The numbers
indicated below the blot are intended to aid in correlating the input
and IP for a given combination of proteins. B, interactions
between HA-tagged Sin3B (long form) and Aiolos, Helios, and Eos were
tested as in A. Immunoblot analysis was performed using HA
antibody to identify interactions between Sin3B (long form) and the
Ikaros family members. C, interactions between endogenous
Mi-2
and Ikaros family members were tested as in A. D, interactions between endogenous HDAC2 and Ikaros family
members were tested as in A. E, comparison of
Class II HDAC interactions with Ikaros family members. 293T cells were
transfected with Myc-tagged HDAC4 (MT-HD4), HA-tagged HDAC5
(HA-HD5), and HDAC7 (HA-HD7) and either
FLAG-tagged Ikaros, Aiolos, Eos, or Helios. Interactions between the
Ikaros family members and these Class II HDACs were determined by IP.
The numbers below the blot are aimed to aid the reader in correlating
the input and IP lanes. F, comparison of Class I
(HD1 and 3) versus Class II (HD4, 5, and 7) HDAC
interactions with Ik1. 293T cells were transfected with FLAG-tagged Ik1
together with either FLAG-tagged HDAC1 (FlagHD1), FLAG-HDAC3
(FlagHD3), Myc-tagged HDAC4 (MT-HD4), HA-tagged
HDAC5 (HA-HD5), or HDAC7 (HA-HD7). Interactions
between the Ikaros family members and these Class II HDACs were
determined by IP with the indicated antibodies. The numbers below the
IB are intended to aid the reader in identifying the input and IP
lanes.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
and Sin3, respectively (13, 22). Ikaros also interacts with the
corepressor CtBP, which despite associating with HDACs, can repress
transcription in an HDAC activity-independent manner (23). In an effort
to determine the role of these corepressor interactions in
Ikaros-mediated repression, we undertook a detailed molecular analysis
of the repression domains of Ikaros. These studies have allowed the
delineation of the minimal repression modules of Ikaros and the
corepressor interactions required for their function. Integrating these
findings in the context of the potent transcriptional repressor, Ik6,
we report the successful construction of the first repression-defective
Ikaros protein.
, and HDAC2 corepressors associate with Ikaros through modules in both the N- and
C-terminal repression domains. At the N terminus, Sin3 and Mi-2
interact with a region spanning the DNA-binding zinc fingers, while
HDAC2 associates with all N-terminal subregions tested to date (albeit
to differing levels) indicating that it can directly bind or be
recruited to Ikaros through independent strategies. At the C terminus,
Mi-2
and HDAC2 interactions with Ikaros are dependent on the region
spanning the zinc fingers involved in dimerization, whereas Sin3 binds
a region immediately adjacent to this region. Interestingly, unlike
Ikaros and its family members, both Mi-2
and HDAC2 do not require
the dimerization function of the C-terminal zinc fingers to associate
with Ikaros. The interactions of Mi-2
, HDAC2, and Sin3 with the
region spanning the DBD of Ikaros and of Mi-2
and HDAC2 with the
dimerization module open up the possibility that they may be involved
in modulating the functions of these domains.
individually or in combination were not defective for repression; this
can be explained by the fact that HDAC2 could interact with all tested
N-terminal subregions. Alternatively, or in addition, unidentified
corepressors may contribute to the redundancy of repression function
that exists for this domain. In contrast, subregions at the C terminus
that could not associate with Mi-2
and HDAC2 were defective for
repression. Thus, the N- and C-terminal repression domains of Ikaros
have significantly different corepressor requirements for repressive function.
binding and also dramatically reduced HDAC2
association, brought repression down to 20% of wild type levels. When
this mutation was coupled with one that prevented CtBP interactions,
the resulting protein was completely incapable of repressing
transcription. Taken together, these data highlight the importance of
the dimerization module for Ik6 to repress transcription and also
suggests that this isoform likely effects repression through the
combinatorial action of Mi-2
, HDAC2, and CtBP.
, HDAC2, and CtBP in Ikaros-mediated
repression. This provides a useful starting point for future studies
aimed at understanding the molecular mechanisms by which Ikaros
represses gene expression.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. B. Morgan for his gift of the Flag-Eos plasmid and Drs. E. Seto, M. Lazar, and R. Evans for their gift of the plasmids encoding Class I and II histone deacetylases.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by National Institutes of Health Grant RO1-AI380342-08.
To whom correspondence should be addressed: CBRC, MGH East, Bldg. 149, 13th St., Charlestown, MA 02129. Tel.: 617-726-4445; Fax: 617-726-4453;
E-mail: katia.georgopoulos@cbrc2.mgh.harvard.edu.
Published, JBC Papers in Press, May 15, 2002, DOI 10.1074/jbc.M201694200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: HD/HDAC, histone deacetylase; RbAp, retinoblastoma-associated proteins; CtBP, C-terminal binding protein; DBD, DNA binding domain; CAT, chloramphenicol acetyltransferase; MT, Myc tag; HA, hemagglutinin; IP, immunoprecipitation; IB, immunoblot; Ik, Ikaros; tk, thymidine kinase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Georgopoulos, K., Winandy, S., and Avitahl, N. (1997) Annu. Rev. Immunol. 15, 155-176[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Morgan, B., Sun, L., Avitahl, N., Andrikopoulos, K., Gonzales, E., Nichogiannopoulou, A., Wu, P., Neben, S., and Georgopoulos, K. (1997) EMBO J. 16, 2004-2013[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Hahm, K.,
Cobb, B. S.,
McCarty, A. S.,
Brown, K. E.,
Klug, C. A.,
Lee, R.,
Akashi, K.,
Weissman, I. L.,
Fisher, A. G.,
and Smale, S. T.
(1998)
Genes Dev.
12,
782-796 |
| 4. | Kelley, C. M., Ikeda, T., Koipally, J., Avitahl, N., Georgopoulos, K., and Morgan, B. A. (1998) Curr. Biol. 8, 508-515[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Honma, Y., Kiyosawa, H., Mori, T., Oguri, A., Nikaido, T., Kanazawa, K., Tojo, M., Takeda, J., Tanno, Y., Yokoya, S., Kawabata, I., Ikeda, H., and Wanaka, A. (1999) FEBS Lett. 447, 76-80[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Hahm, K.,
Ernst, P., Lo, K.,
Kim, G. S.,
Turck, C.,
and Smale, S. T.
(1994)
Mol. Cell. Biol.
14,
7111-7123 |
| 7. | Molnár, A., and Georgopoulos, K. (1994) Mol. Cell. Biol. 14, 785-794 |
| 8. | Sun, L., Liu, A., and Georgopoulos, K. (1996) EMBO J. 15, 5358-5369[Medline] [Order article via Infotrieve] |
| 9. | Georgopoulos, K., Bigby, M., Wang, J.-H., Molnár, A., Wu, P., Winandy, S., and Sharpe, A. (1994) Cell 79, 143-156[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Winandy, S., Wu, P., and Georgopoulos, K. (1995) Cell 83, 289-299[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Wang, J., Nichogiannopoulou, A., Wu, L., Sun, L., Sharpe, A., Bigby, M., and Georgopoulos, K. (1996) Immunity 5, 537-549[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Wang, J.-H., Avitahl, N., Cariappa, A., Friedrich, C., Ikeda, T., Renold, A., Andrikopoulos, K., Liang, L., Pillai, S. A., and Georgopoulos, K. (1998) Immunity 9, 543-553[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Koipally, J., Renold, A., Kim, J., and Georgopoulos, K. (1999) EMBO J. 18, 3090-3100[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Ahringer, J. (2000) Trends Genet. 16, 351-356[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Gray, S. G., and Ekstrom, T. J. (2001) Exp. Cell Res. 262, 75-83[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Knoepfler, P. S., and Eisenman, R. N. (1999) Cell 99, 447-450[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Ballas, N., Battaglioli, E., Atouf, F., Andres, M. E., Chenoweth, J., Anderson, M. E., Burger, C., Moniwa, M., Davie, J. R., Bowers, W. J., Federoff, H. J., Rose, D. W., Rosenfeld, M. G., Brehm, P., and Mandel, G. (2001) Neuron 31, 353-365[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Humphrey, G. W.,
Wang, Y.,
Russanova, V. R.,
Hirai, T.,
Qin, J.,
Nakatani, Y.,
and Howard, B. H.
(2001)
J. Biol. Chem.
276,
6817-6824 |
| 19. |
You, A.,
Tong, J. K.,
Grozinger, C. M.,
and Schreiber, S. L.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
1454-1458 |
| 20. |
Sif, S.,
Saurin, A. J.,
Imbalzano, A. N.,
and Kingston, R. E.
(2001)
Genes Dev.
15,
603-618 |
| 21. |
Huang, E. Y.,
Zhang, J.,
Miska, E. A.,
Guenther, M. G.,
Kouzarides, T.,
and Lazar, M. A.
(2000)
Genes Dev.
14,
45-54 |
| 22. | Kim, J., Sif, S., Jones, B., Jackson, A., Koipally, J., Heller, B., Winandy, S., Veil, A., Sawyer, A., Ikeda, T., Kingston, R., and Georgopoulos, K. (1999) Immunity 10, 345-355[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Koipally, J.,
and Georgopoulos, K.
(2000)
J. Biol. Chem.
275,
19594-19602 |
| 24. | Momeni, P., Glockner, G., Schmidt, O., von Holtum, D., Albrecht, B., Gillessen-Kaesbach, G., Hennekam, R., Meinecke, P., Zabel, B., Rosenthal, A., Horsthemke, B., and Ludecke, H. J. (2000) Nat. Genet. 24, 71-74[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Malik, T. H., Shoichet, S. A., Latham, P., Kroll, T. G., Peters, L. L., and Shivdasani, R. A. (2001) EMBO J. 20, 1715-1725[CrossRef][Medline] [Order article via Infotrieve] |
| 26. |
Georgopoulos, K.,
Moore, D.,
and Derfler, B.
(1992)
Science
258,
808-812 |
| 27. |
Perdomo, J.,
Holmes, M.,
Chong, B.,
and Crossley, M.
(2000)
J. Biol. Chem.
275,
38347-38354 |
| 28. |
Zhang, C. L.,
McKinsey, T. A., Lu, J. R.,
and Olson, E. N.
(2001)
J. Biol. Chem.
276,
35-39 |
| 29. |
Burke, L. J.,
and Baniahmad, A.
(2000)
FASEB J.
14,
1876-1888 |
This article has been cited by other articles:
![]() |
R. Sridharan and S. T. Smale Predominant Interaction of Both Ikaros and Helios with the NuRD Complex in Immature Thymocytes J. Biol. Chem., October 12, 2007; 282(41): 30227 - 30238. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Caballero, F. Setien, L. Lopez-Serra, M. Boix-Chornet, M. F. Fraga, S. Ropero, D. Megias, M. Alaminos, E. M. Sanchez-Tapia, M. C. Montoya, et al. Combinatorial effects of splice variants modulate function of Aiolos J. Cell Sci., August 1, 2007; 120(15): 2619 - 2630. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hu, S. M. Sharma, A. Bronisz, R. Srinivasan, U. Sankar, and M. C. Ostrowski Eos, MITF, and PU.1 Recruit Corepressors to Osteoclast-Specific Genes in Committed Myeloid Progenitors Mol. Cell. Biol., June 1, 2007; 27(11): 4018 - 4027. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bandyopadhyay, M. Dure, M. Paroder, N. Soto-Nieves, I. Puga, and F. Macian Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells Blood, April 1, 2007; 109(7): 2878 - 2886. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. R. Quinlan, A. Verger, A. Kwok, S. H. Y. Lee, J. Perdomo, M. Nardini, M. Bolognesi, and M. Crossley Role of the C-Terminal Binding Protein PXDLS Motif Binding Cleft in Protein Interactions and Transcriptional Repression Mol. Cell. Biol., November 1, 2006; 26(21): 8202 - 8213. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Oswald, M. Winkler, Y. Cao, K. Astrahantseff, S. Bourteele, W. Knochel, and T. Borggrefe RBP-J{kappa}/SHARP Recruits CtIP/CtBP Corepressors To Silence Notch Target Genes Mol. Cell. Biol., December 1, 2005; 25(23): 10379 - 10390. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Westman, J. Perdomo, M. Sunde, M. Crossley, and J. P. Mackay The C-terminal Domain of Eos Forms a High Order Complex in Solution J. Biol. Chem., October 24, 2003; 278(43): 42419 - 42426. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |